OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn, Simon Haroutounian, Andrea G. Hohmann, et al.
Pain (2021) Vol. 162, Iss. 1, pp. S5-S25
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 90

Cannabis-Based Products for Chronic Pain
Marian McDonagh, Benjamin J. Morasco, Jesse Wagner, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 8, pp. 1143-1153
Closed Access | Times Cited: 79

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 58

Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
Jonathan Vela, Lene Dreyer, Kristian Kjær Petersen, et al.
Pain (2021) Vol. 163, Iss. 6, pp. 1206-1214
Open Access | Times Cited: 80

Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
Frank Petzke, Thomas R. Tölle, Mary‐Ann Fitzcharles, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 31-44
Open Access | Times Cited: 62

Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Giuseppina Crescente, Giuseppe Minervini, Carmela Spagnuolo, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 106-106
Open Access | Times Cited: 50

Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action
Shuangyuan Hu, Jundong Wang, Enmei Liu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106481-106481
Closed Access | Times Cited: 43

Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism
Yuying Liao, Huibing Zhang, Qingya Shen, et al.
Cell (2023) Vol. 186, Iss. 26, pp. 5784-5797.e17
Open Access | Times Cited: 37

Differential regulation of Cav3.2 and Cav2.2 calcium channels by CB1 receptors and cannabidiol
Erika K. Harding, Ivana A. Souza, María A. Gandini, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 12, pp. 1616-1633
Open Access | Times Cited: 25

Mechanisms of comorbidity between Alzheimer's disease and pain
Kaifang Yao, Shenjun Wang, Zhifang Xu, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1

Designer cannabinoids could be the key to pain relief without adverse effects.
Iain R. Greig, Ruth A. Ross
PubMed (2025)
Closed Access | Times Cited: 1

Role of Neuroimmune Crosstalk in Mediating the Anti-inflammatory and Analgesic Effects of Acupuncture on Inflammatory Pain
Baomin Dou, Yanan Li, Jie Ma, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 52

Endocannabinoid-Based Therapies
Daniele Piomelli, Alex Mabou Tagne
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 483-507
Open Access | Times Cited: 52

Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Raquel Maria Pereira Campos, Andrey F. L. Aguiar, Yolanda Paes-Colli, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 44

Chronic Pain and Psychiatric Conditions
Keira J.A. Johnston, Laura M. Huckins
Complex Psychiatry (2022) Vol. 9, Iss. 1-4, pp. 24-43
Open Access | Times Cited: 30

Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 29

Chronic Pain–Related Cognitive Deficits: Preclinical Insights into Molecular, Cellular, and Circuit Mechanisms
Siyi Han, Jie Wang, Wen Zhang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8123-8143
Closed Access | Times Cited: 8

Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
Kawthar Safi, Jan Sobieraj, Michał Błaszkiewicz, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 307-307
Open Access | Times Cited: 7

A Cross-Sectional Survey Study of Cannabis Use for Fibromyalgia Symptom Management
Abhinav Singla, Christopher V. Anstine, Linda Huang, et al.
Mayo Clinic Proceedings (2024) Vol. 99, Iss. 4, pp. 542-550
Closed Access | Times Cited: 6

Review of the Use of Medicinal Cannabis Products in Palliative Care
James Troyer, Kimberson Tanco
Cancers (2024) Vol. 16, Iss. 7, pp. 1412-1412
Open Access | Times Cited: 5

Serum levels of hydroxylated metabolites of arachidonic acid cross-sectionally and longitudinally predict knee pain progression: an observational cohort study
James Turnbull, Rakesh Roshan Jha, Peter R.W. Gowler, et al.
Osteoarthritis and Cartilage (2024) Vol. 32, Iss. 8, pp. 990-1000
Closed Access | Times Cited: 5

Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats
Rosaria Greco, Chiara Demartini, Miriam Francavilla, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 830-830
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top